Metabolic and Cardiovascular Effects of Armolipid Plus in Subjects With Metabolic Syndrome

Clinical trial NCT02295176 · COMPLETED

Trial details

NCT number: NCT02295176
Sponsor: Rottapharm
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Metabolic Syndrome Insulin-resistance Left Ventricular Hypertrophy

Start date: 2013-04-01
Primary completion: 2015-03-01
Enrollment: 159

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.